{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:40:46Z","timestamp":1792633246753,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ejso.2016.10.020","type":"journal-article","created":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T02:49:01Z","timestamp":1478314141000},"page":"689-695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1094-1819","authenticated-orcid":false,"given":"A.","family":"Kakkos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bresson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cousin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lervat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bogart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Meurant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"El Bedoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Decanter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hannebicque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Regis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hamdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Penel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Tresch-Bruneel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Narducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"692","key":"10.1016\/j.ejso.2016.10.020_bib1","first-page":"e11","article-title":"Complete catheter disconnection and migration of an implantable venous access device: the disconnected cap sign","volume":"24","author":"Faraj","year":"2010","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejso.2016.10.020_bib2","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.4065\/81.9.1159","article-title":"The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies","volume":"81","author":"Maki","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ejso.2016.10.020_bib3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/112972980400500407","article-title":"Complications and management of long-term central venous access catheters and ports","volume":"5","author":"Yildizeli","year":"2004","journal-title":"J Vasc Access"},{"key":"10.1016\/j.ejso.2016.10.020_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0300-2977(00)00083-8","article-title":"Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems","volume":"57","author":"Hartkamp","year":"2000","journal-title":"Neth J Med"},{"issue":"Suppl. 5","key":"10.1016\/j.ejso.2016.10.020_bib5","doi-asserted-by":"crossref","first-page":"v152","DOI":"10.1093\/annonc\/mdv296","article-title":"Central venous access in oncology: ESMO clinical practice guidelines","volume":"26","author":"Sousa","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2016.10.020_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00520-008-0498-x","article-title":"It appears to be safe to start chemotherapy on the day of implantation through subcutaneous venous port catheters in inpatient setting","volume":"17","author":"Ozdemir","year":"2009","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejso.2016.10.020_bib7","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s10147-015-0830-7","article-title":"Is there any effect of first-day usage of a totally implantable venous access device on complications?","volume":"20","author":"Karanlik","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ejso.2016.10.020_bib8","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ejso.2011.06.016","article-title":"Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre","volume":"37","author":"Narducci","year":"2011","journal-title":"Eur J Surg Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.ejso.2016.10.020_bib9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0195-6701(07)60002-4","article-title":"epic2: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England","volume":"65","author":"Pratt","year":"2007","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ejso.2016.10.020_bib10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3109\/00016925309136722","article-title":"Catheter replacement of the needle in percutaneous arteriography; a new technique","volume":"39","author":"Seldinger","year":"1953","journal-title":"Acta Radiol"},{"key":"10.1016\/j.ejso.2016.10.020_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.suronc.2012.02.003","article-title":"Update on totally implantable venous access devices","volume":"21","author":"Zaghal","year":"2012","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ejso.2016.10.020_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejso.2008.01.020","article-title":"An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction","volume":"35","author":"Ignatov","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2016.10.020_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12013-014-0443-1","article-title":"Infections related to totally implantable venous-access ports: long-term experience in one center","volume":"72","author":"Ji","year":"2015","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.ejso.2016.10.020_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5090\/kjtcs.2014.47.1.26","article-title":"A retrospective clinical study: complications of totally implanted central venous access ports","volume":"47","author":"Seok","year":"2014","journal-title":"Korean J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ejso.2016.10.020_bib15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00268-015-3233-z","article-title":"Does the implantation technique for totally implantable venous access ports (TIVAPs) influence long-term outcome?","volume":"40","author":"Biacchi","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2016.10.020_bib16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1023\/A:1008392423469","article-title":"Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days","volume":"9","author":"Biffi","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2016.10.020_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejso.2007.04.003","article-title":"A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients","volume":"34","author":"Araujo","year":"2008","journal-title":"Eur J Surg Oncol"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798316309593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798316309593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T05:24:37Z","timestamp":1568525077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798316309593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0748798316309593"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2016.10.020","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2016.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}